Oral hypoglycaemic effect of GLP-1 and DPP4 inhibitor based nanocomposites in a diabetic animal model-Reference-Cited by-同舟云学术

Oral hypoglycaemic effect of GLP-1 and DPP4 inhibitor based nanocomposites in a diabetic animal model

Published:2016-06 Issue: Volume:232 Page:113-119
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Shrestha Neha,Araújo Francisca,Shahbazi Mohammad-Ali,Mäkilä Ermei,Gomes Maria João,Airavaara Mikko,Kauppinen Esko I.,Raula Janne,Salonen Jarno,Hirvonen Jouni,Sarmento Bruno,Santos Hélder A.^ORCID

Funder

Academy of Finland

University of Helsinki Research Funds

Biocentrum Helsinki

European Research Council

European Regional Development Fund

Fundação para a Ciência e a Tecnologia

National Strategic Reference Framework

Finnish Cultural Foundation

FCT

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference47 articles.

1. Future directions for peptide therapeutics development;Kaspar;Drug Discov. Today,2013

2. Protein therapeutics: a summary and pharmacological classification;Leader;Nat. Rev. Drug Discov.,2008

3. Protein drug stability: a formulation challenge;Frokjaer;Nat. Rev. Drug Discov.,2005

4. Emerging trends in oral delivery of peptide and protein drugs;Mahato;Crit. Rev. Ther. Drug Carrier Syst.,2003

5. Is the oral route possible for peptide and protein drug delivery;Morishita;Drug Discov. Today,2006

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Porous Silicon Microparticles Enable Sustained Release of GLP‐1R Agonist Peptides for the Treatment of Type 2 Diabetes;Advanced Therapeutics;2024-08-10

2. The role of nanosystems in the delivery of glucose-lowering drugs for the preemption and treatment of diabetes-associated atherosclerosis;American Journal of Physiology-Cell Physiology;2024-05-01

3. Enhancing the Therapeutic Efficacy of GLP-1 for Hyperglycemia Treatment: Overcoming Barriers of Oral Gene Therapy with Taurocholic Acid-Conjugated Protamine Sulfate and Calcium Phosphate;ACS Nanoscience Au;2024-04-05

4. New insights into nanomedicines for oral delivery of glucagon‐like peptide‐1 analogs;WIREs Nanomedicine and Nanobiotechnology;2024-03

5. Biochemotaxis‐Oriented Engineering Bacteria Expressing GLP‐1 Enhance Diabetes Therapy by Regulating the Balance of Immune;Advanced Healthcare Materials;2024-02-11